Serial 88779671
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88779671
- Registration number
- 6732291
- Mark type
- Design / logo
- Filed
- 30 Jan 2020
- Published for opposition
- 02 Jun 2020
- Registered
- 24 May 2022
- Attorney of record
- Mary L. Grieco
Goods and services
- Class 005 — Pharmaceuticals: aspirin-based analgesics; antipyretic and anti-inflammatory oral preparations in the form of liquid-filled capsules; oral preparations in the form of liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
Owner
- PLX ACQUISITION COMPANY, LLC, BUFFALO, NY, US
- PLx Pharma Inc., Sparta, NJ, US
- PLx Pharma Inc., Sparta, NJ, US
- PLx Pharma Inc., Sparta, NJ, US
Prosecution history
- 20 Sept 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Feb 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jan 2022 — NON-FINAL ACTION E-MAILED
- 05 Jan 2022 — SU - NON-FINAL ACTION - WRITTEN
- 08 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Nov 2021 — USE AMENDMENT FILED
- 06 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Nov 2021 — TEAS STATEMENT OF USE RECEIVED